Eching, Germany

Henning Lauterbach

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Echinq, DE (2021)
  • Eching, DE (2019 - 2023)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Henning Lauterbach: Innovator in Cancer Treatment

Introduction

Henning Lauterbach is a prominent inventor based in Eching, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 7 patents to his name, Lauterbach is recognized for his groundbreaking work in therapeutic methods aimed at improving patient outcomes.

Latest Patents

Lauterbach's latest patents focus on advanced therapies for treating cancer. One notable invention is a therapy that utilizes intratumoral or intravenous administration of a recombinant MVA encoding 4-1BBL (CD137L) and/or CD40L. This invention relates to a composition and methods designed to reduce tumor volume and increase the survival rate of cancer patients. The composition includes a recombinant MVA encoding a Tumor Associated Antigen (TAA) along with 4-1BBL and/or CD40L, which can be administered in various ways, including intravenously and intratumorally.

Another significant patent involves a combination therapy for cancer treatment that includes an antibody and intravenous administration of a recombinant MVA. This pharmaceutical combination aims to reduce tumor volume and enhance the survival of cancer patients by administering a recombinant MVA encoding a tumor-associated antigen alongside an antibody.

Career Highlights

Lauterbach's career is marked by his dedication to advancing cancer therapies. His work at Bavarian Nordic A/S has positioned him at the forefront of innovative cancer treatment solutions. His research has not only contributed to the scientific community but has also provided hope for patients battling cancer.

Collaborations

Henning Lauterbach has collaborated with notable colleagues in his field, including Hubertus Hochrein and José Medina Echeverz. These collaborations have further enriched his research and development efforts, leading to impactful advancements in cancer treatment.

Conclusion

Henning Lauterbach is a distinguished inventor whose work in cancer treatment has the potential to change lives. His innovative patents and dedication to research exemplify the importance of continued advancements in medical science. Through his contributions, Lauterbach is paving the way for more effective cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…